eli lilly gip glp-1 Lilly's diabetes drug Mounjaro receives expanded approval for weight management in Korea < Pharma < Article Eli Lilly launches weight loss
Description
Our robust approach to helping plan sponsors control costs for weight management GLP-1s includes flexible coverage, cost and care management strategies.
GLP-1 and GIP are hormones that are released soon after you eat a meal
To help decision-makers understand what's driving these costs, Navitus is hosting a live webinar on Tuesday, July 29 at 3:00 p.m
The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.
Berberine Supports insulin sensitivity and weight regulation
Yellow Persistent or worsening patterns such as poor intake, recurring nausea, training decline, or function getting harder
